News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Johnson & Johnson (JNJ)'s DePuy Aims to Reverse $8.3 Million Metal Hip Implant Loss


4/23/2013 8:29:19 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Johnson & Johnson subsidiary DePuy Orthopaedics asks a California judge to stay an $8.3 million jury decision against the company while attorneys file an appeal. Johnson & Johnson (NYSE:JNJ) and its DePuy Orthopaedics subsidiary are hoping to dodge an $8.3 million judgment stemming from the company's 1st metal-on-metal hip implant complaint to go to trial. DePuy last week asked the Los Angeles Superior Court to put a hold on the jury's decision in a trial brought by patient Loren Kransky, who claimed his ASR hip failed less than 5 years after he received it.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES